Inventor · disambiguated record
Henry Pauls
Also filed as: PAULS HENRY W · PAULS Henry
12 granted patents·3 pending applications·223 citations·filing 1983–2013
92Inventor score
Files withRHONE POULENC RORER PHARMA5PAULS Henry3AVENTIS PHARMA GMBH2AFFINIUM PHARM INC1AVENTIS PHARMA INC1
Top patents by PatentIndex Score
15 records- 0190US5612353ASubstituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compoundsRHONE POULENC RORER PHARMA·Filed 1995·Granted Mar 18, 1997·59 cites·12 claims
- 0289US8263613B2Salts, prodrugs and polymorphs of fab I inhibitorsPAULS Henry·Filed 2008·Granted Sep 11, 2012·9 cites·4 claims
- 0387US6559313B2Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic propertiesAVENTIS PHARMA GMBH·Filed 2002·Granted May 6, 2003·21 cites·2 claims
- 0487US5441946APhosphonate derivatives of lipophilic aminesRHONE POULENC RORER PHARMA·Filed 1994·Granted Aug 15, 1995·34 cites·17 claims
- 0582US6376472B1Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesAVENTIS PHARMA INC·Filed 1998·Granted Apr 23, 2002·24 cites·15 claims
- 0682US5563128APhosphonate derivatives of lipophilic aminesRHONE POULENC RORER PHARMA·Filed 1995·Granted Oct 8, 1996·31 cites·22 claims
- 0780US8450307B2Therapeutic agents, and methods of making and using the sameSARGENT BRUCE J·Filed 2005·Granted May 28, 2013·9 cites·22 claims
- 0870US9862737B2Salts, prodrugs and polymorphs of fab I inhibitorsDEBIOPHARM INT SA·Filed 2013·Granted Jan 9, 2018·0 cites·8 claims
- 0959US5556990APolyarylcarbamoylaza- and -carbamoylalkanedioic acidsRHONE POULENC RORER PHARMA·Filed 1994·Granted Sep 17, 1996·8 cites·19 claims
- 1059US2013150400A1Salts, prodrugs and polymorphs of fab i inhibitorsPAULS Henry·Filed 2012·Application pending·0 cites
- 1156US4496456AMethod for preparing thin regenerated cellulose membranes of high flux and selectivity for organic liquids separationsEXXON RESEARCH ENGINEERING CO·Filed 1983·Granted Jan 29, 1985·16 cites·30 claims
- 1252US5958918ASubstituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compoundsRHONE POULENC RORER PHARMA·Filed 1997·Granted Sep 28, 1999·5 cites·57 claims
- 1348US2014107106A1Therapeutic agents, and methods of making and using the sameAFFINIUM PHARM INC·Filed 2013·Application pending·0 cites
- 1445US6602864B1Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compoundsAVENTIS PHARMA GMBH·Filed 1998·Granted Aug 5, 2003·7 cites·33 claims
- 1543US2009156578A13-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial AgentsPAULS Henry·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →